Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transformation of fibroblast‐like synoviocytes in rheumatoid arthritis; from a friend to foe
Mohammad Javad Mousavi, Jafar Karami, Saeed Aslani, et al.
Autoimmunity Highlights (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Modulation of redox-sensitive transcription factors with polyphenols as pathogenetically grounded approach in therapy of systemic inflammatory response
V.О. Kostenko, O. Ye. Akimov, O.M. Gutnik, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15551-e15551
Open Access | Times Cited: 55
Comprehensive overview of microRNA function in rheumatoid arthritis
Xiaole Peng, Qing Wang, Wenming Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 51
Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?
Tamás Németh, György Nagy, Thomas Pap
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 8, pp. 1055-1064
Open Access | Times Cited: 53
Analysis and Experimental Validation of Rheumatoid Arthritis Innate Immunity Gene CYFIP2 and Pan-Cancer
Zhenyu Zhao, Shaojie He, XinCheng Yu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Pharmacological and Therapeutic Applications of Esculetin
Sourbh Suren Garg, Jeena Gupta, Debasis Sahu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12643-12643
Open Access | Times Cited: 42
Therapeutic Antibodies in Medicine
Prerna Sharma, Rahul V. Joshi, Robert C. Pritchard, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6438-6438
Open Access | Times Cited: 29
Rheumatoid arthritis: the old issue, the new therapeutic approach
Mahnaz Babaahmadi, Behnoosh Tayebi, Nima Makvand Gholipour, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis
Hongyan Qian, Chaoqiong Deng, Shiju Chen, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 11
Metabolic changes in fibroblast-like synoviocytes in rheumatoid arthritis: state of the art review
Zhipeng Hu, Yuan Li, Lili Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
A Less‐is‐More Strategy for Mitochondria‐Targeted Photodynamic Therapy of Rheumatoid Arthritis
Qingting Zuo, Jiayan Lyu, Xinran Shen, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 8
L-selectin Promotes Migration, Invasion and Inflammatory Response of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via NF-kB Signaling Pathway
Weijie Wu, Zhen Cheng, Yunyi Nan, et al.
Inflammation (2025)
Open Access | Times Cited: 1
The synovial fluid fibroblast-like synoviocyte: A long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis
Dorra Elhaj Mahmoud, Wajih Kaabachi, Nadia Sassi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Epigenetic Regulation in the Pathogenesis of Rheumatoid Arthritis
Chao Yang, Dan Li, Dehong Teng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Rheumatoid arthritis molecular targets and their importance to flavonoid‐based therapy
Ana T. Rufino, Marisa Freitas, Carina Proença, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 497-538
Open Access | Times Cited: 19
Comprehensive insights into rheumatoid arthritis: Pathophysiology, current therapies and herbal alternatives for effective disease management
Amrita Chatterjee, Monisha Jayaprakasan, Anirban Kr Chakrabarty, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2764-2799
Closed Access | Times Cited: 7
Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis
Fang Qiu, Duoli Xie, Hongzhen Chen, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225565
Closed Access | Times Cited: 7
Role of T Cells in the Pathogenesis of Rheumatoid Arthritis: Focus on Immunometabolism Dysfunctions
Maryam Masoumi, ‬‬Samira Alesaeidi, Hossein Khorramdelazad, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 88-102
Closed Access | Times Cited: 19
Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases
Julie Sarrand, Muhammad S. Soyfoo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14481-14481
Open Access | Times Cited: 12
Can pyroptosis be a new target in rheumatoid arthritis treatment?
Dengqiang Wu, Yujie Li, Ranxing Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Epigenetic Regulatory Axis MIR22‐TET3‐MTRNR2L2 Represses Fibroblast‐Like Synoviocyte–Mediated Inflammation in Rheumatoid Arthritis
Yilong Fang, Wei Huang, Xiangling Zhu, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 6, pp. 845-856
Closed Access | Times Cited: 4
A synergistic effect of triptolide and curcumin on rheumatoid arthritis by improving cell proliferation and inducing cell apoptosis via inhibition of the IL-17/NF-κB signaling pathway
Chaofeng Zhang, Yiyang Weng, Haibin Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 112953-112953
Open Access | Times Cited: 4
LAMP3-mediated epithelial-mesenchymal transition promotes the invasion and excessive proliferation of fibroblast-like synoviocytes in rheumatoid arthritis
Wenxian Zhou, Hui Cheng, Chia‐Kwung Fan, et al.
Journal of Autoimmunity (2025) Vol. 151, pp. 103359-103359
Closed Access
Qufeng epimedium decoction alleviates rheumatoid arthritis through CYLD-antagonized NF-kB activation by deubiquitinating Sirt1
Zhiming Wu, Peng Zhang, Wen-Yan Huang, et al.
Immunobiology (2025), pp. 152875-152875
Open Access
The LKB1–AMPK Signaling Axis Modulates Ferroptosis in Fibroblast-Like Synoviocytes Derived from Rheumatoid Arthritis
Ha‐Reum Lee, Su‐Jin Yoo, Jinhyun Kim, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 321-321
Open Access
Review of mesenchymal stem cell-derived exosomes and their potential therapeutic roles in treating rheumatoid arthritis
S Haji Aghajani, S. A. Maboudi, Iman Seyhoun, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top